Clinical Trials


Technology-based Analysis of Movement Disorders

Intervention Type: Device
Study Type: Interventional
Sponsors: University College, London
Participants: 50
Objectives: To generate pilot data to investigate the feasibility and the potential use in clinical practice of technology based objective measures of motor performances in patients affected by different movement disorders. To correlate kinematics findings with demographic and clinical details. Trial design and methods: Participants enrolled in prof. Bhatia's movement disorders clinic, will be classifies according to the main movement disorder, specifically, tremor, parkinsonism, dystonia, chorea, ataxia. In the study visit (one day only), they will undergo a clinical evaluation using the appropriate clinical scales (respectively, Fahn-Tolosa-Marin tremor rating scale, MDS-UPDRS Part III, Toronto Western Spasmodic Torticollis Rating Scale 2, Unified Hungtington Disease Rating scale and Scale for the Assessment and Rating of Ataxia) and a kinematic evaluation, using wearables and an infra-red and LED markers system. Then the protocol is concluded and they will continue the routine clinical follow-up
* Consult with your doctor before enrolling in clinical trials.
kailash P Bhatia
020 3448 4229
giulia di lazzaro
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: No
Inclusion Criteria:
- clinical diagnosis of parkinsonism and/or dystonia and/or tremor due to:
- idiopatic parkinson's disease
- atypical parkinsonism
- sporadic or inherited/genetic dystonia
- young-onset Parkinson's disease
- Ataxia syndrome
- Choereic syndrome
- Essential tremor
- Dystonic tremor
- 18 to 80 years of age
- Willing and able to provide informed consent
- able to walk unassisted
Exclusion Criteria:
- Change in pharmacological therapy in the last 3 months.
- Participated in a clinical drug trial up to 3 months before inclusion into the present study
- Orthopaedical comorbidities affecting gait or posture.
- Cognitive deficit

View Article From Source